Position in NVCR
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$213,716
-$69,877 QoQ
Shares Held
19,607
-10.6% QoQ
Ownership
0.017%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVCR Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Mar 31, 2026Arax Advisory Partners holds $13,907,312 across 61 Medical Devices names. NVCR ranks #8 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
41,591 | $4,270,147 | |
| 2 | SYK |
Stryker Corp
|
7,835 | $2,574,502 | |
| 3 | ZBH |
Zimmer Biomet Holdings, Inc.
|
19,826 | $1,792,666 | |
| 4 | MDT |
Medtronic plc
|
15,381 | $1,332,763 | |
| 5 | BSX |
Boston Scientific Corp
|
17,877 | $1,121,781 | |
| 6 | GMED |
Globus Medical Inc
|
3,793 | $326,804 | |
| 7 | DXCM |
Dexcom Inc
|
4,379 | $275,001 | |
| 8 | NVCR |
NovoCure Ltd
This page
|
19,607 | $213,716 |
All Filings in NVCR
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $213,716 | 19,607 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $283,593 | 21,933 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $448,918 | 34,746 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $33,286 | 1,870 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $35,158 | 1,973 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $27,803 | 933 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $18,881 | 1,208 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $8,290 | 484 | Shares | Sole | 2024-08-06 | |
| No filing history on record for this holder in this stock. | ||||||